• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MediWound Ltd. - Ordinary Shares (NQ:MDWD)

14.36 +0.06 (+0.41%)
Streaming Delayed Price Updated: 1:43 PM EDT, Aug 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MediWound Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >
News headline image
MDWD Stock Earnings: MediWound Misses EPS, Beats Revenue for Q2 2024 ↗
August 14, 2024
MDWD stock results show that MediWound missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update
August 14, 2024
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Announces Positive Results from the U.S. NexoBrid® Expanded Access Protocol (NEXT)
August 05, 2024
NEXT Confirms NexoBrid's Proven Safety and Efficacy in Eschar Removal, Significantly Reducing Surgical Procedures for Burn Patients 
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound to Report Second Quarter 2024 Financial Results
August 02, 2024
Conference Call and Webcast Scheduled for Wednesday, August 14th at 8:30 am Eastern Time 
From MediWound Ltd.
Via GlobeNewswire
News headline image
Preview: MediWound's Earnings ↗
March 20, 2024
 
Via Benzinga
News headline image
Recap: MediWound Q3 Earnings ↗
November 21, 2023
 
Via Benzinga
News headline image
MediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results for Venous Leg Ulcers
July 29, 2024
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program
July 16, 2024
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Announces $25 Million Strategic Private Placement Financing
July 15, 2024
Mölnlycke Health Care, a global leader in innovative wound care solutions, leads the PIPE with a $15 million investment 
From MediWound Ltd.
Via GlobeNewswire
News headline image
Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
July 05, 2024
Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has resigned as the Chief Financial Officer for personal and family 
Via Benzinga
News headline image
US Stocks Mixed; Jobs Figures Top Estimates For June ↗
July 05, 2024
 
Via Benzinga
News headline image
Why Sharps Technology Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket ↗
July 05, 2024
Shares of Sharps Technology, Inc. (NASDAQ:STSS) rose sharply in today's pre-market trading after the company announced it received two purchase orders for a total of approximately one million... 
Via Benzinga
News headline image
MDWD Stock Earnings: MediWound Beats EPS, Beats Revenue for Q1 2024 ↗
May 29, 2024
MDWD stock results show that MediWound beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
MediWound Reports First Quarter 2024 Financial Results and Provides Company Update
May 29, 2024
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound to Report First Quarter 2024 Financial Results
May 22, 2024
Conference Call and Webcast Scheduled for Wednesday, May 29th at 8:30 am Eastern Time 
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences
April 25, 2024
From MediWound Ltd.
Via GlobeNewswire
MediWound Ltd. (NASDAQ: MDWD) Sets New 52-Week High in Wednesday Session
April 17, 2024
Via Investor Brand Network
News headline image
MDWD Stock Earnings: MediWound Beats EPS, Beats Revenue for Q4 2023 ↗
March 21, 2024
MDWD stock results show that MediWound beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
March 21, 2024
From MediWound Ltd.
Via GlobeNewswire
News headline image
Earnings Scheduled For March 21, 2024 ↗
March 21, 2024
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million. 
Via Benzinga
News headline image
MediWound to Report Fourth Quarter and Full Year 2023 Financial Results
March 14, 2024
Conference Call and Webcast Scheduled for Thursday, March 21st at 8:30 am Eastern Time 
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study
February 12, 2024
Results demonstrate superiority of EscharEx®, a bromelain-based gel vs. SANTYL®, a collagenase ointment, in wound debridement, promotion of granulation tissue, and time to wound closure in patients... 
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound to Participate in Two Upcoming Investor Conferences
February 05, 2024
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients with Severe Thermal Burns
January 09, 2024
From MediWound Ltd.
Via GlobeNewswire
News headline image
Innovative Burn Care: MediWound Bags Additional DoD Grant For NexoBrid Development ↗
December 28, 2023
Biopharmaceutical company MediWound Ltd (NASDAQ: MDWD) reported that the U.S. 
Via Benzinga
News headline image
MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army
December 28, 2023
Awarded additional $6.7 million to advance NexoBrid as a non-surgical field care solution; R&D project budget increased to $14.4 million 
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Announces Peer-Reviewed Publication of EscharEx® Mechanism of Action Study Assessing Its Effects on Biofilm and Microbial Loads
December 21, 2023
Results show EscharEx to be safe and effective, and suggest it can go beyond traditional expectations for enzymatic debridement 
From MediWound Ltd.
Via GlobeNewswire
News headline image
Earnings Scheduled For November 21, 2023 ↗
November 21, 2023
Companies Reporting Before The Bell • Golden Ocean Group (NASDAQ:GOGL) is likely to report quarterly earnings at $0.11 per share on revenue of $149.42 million. 
Via Benzinga
News headline image
MediWound Reports Third Quarter 2023 Financial Results and Provides Company Update
November 21, 2023
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer
November 21, 2023
From MediWound Ltd.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap